本报讯 （记者梁傲男）12月23日，由北京大学中国卫生经济研究中心指导，首都医科大学附属北京同 仁医院、医学人工智能研究与验证工业和信息化部重点实验室、致盲性眼病防控及智能诊疗北京市重点 实验室、爱康集团与鹰瞳科技联合发起，人民健康支持的2025版基于视网膜AI评估的《六百万体检人 群健康蓝皮书》（以下简称《蓝皮书》）在北京正式发布。 发布会上，首都医科大学附属北京同仁医院副院长魏文斌，爱康集团首席执行官张黎刚，鹰瞳科技董事 长张大磊先后发言，就视网膜人工智能技术的应用发展、创新突破与普惠实践等进行了深入分享。 为了实现最大化的医疗普惠，2018年，爱康集团全面启动iKangAI+计划，不断引入人工智能产品，赋 能传统体检。如今经过7年时间的探索，已打造出一个集眼底、肺、乳腺、心脏、脑血管、牙齿、骨骼 等10余款AI专项健康筛查产品之力的"爱康AI矩阵"。 这是爱康集团与鹰瞳科技连续第七年发布基于视网膜人工智能评估的《蓝皮书》，累计样本量突破600 万大关，连续进行视网膜人工智能评估的人群首次超过100万，通过动态追踪我国体检人群的眼健康及 全身健康状况、风险分布，为公共卫生研究提供了基于脱敏大数据的真实且具 ...

2025版基于视网膜人工智能评估的 《六百万体检人群健康蓝皮书》正式发布 这是爱康集团与鹰瞳科技连续第七年发布基于视网膜人工智能评估的《体检人群健康蓝皮书》，累计样 本量突破600万大关，连续进行视网膜人工智能评估的人群更是首次超过100万，通过动态追踪我国体检 人群的眼健康及全身健康状况、风险分布，为公共卫生研究提供了基于脱敏大数据的真实且具有参考价 值的"观测窗口"。 发布会上，首都医科大学附属北京同仁医院副院长魏文斌，爱康集团首席执行官张黎刚，鹰瞳科技董事 12月23日，由北京大学中国卫生经济研究中心指导，首都医科大学附属北京同仁医院、医学人工智能研 究与验证工业和信息化部重点实验室、致盲性眼病防控及智能诊疗北京市重点实验室、爱康集团与鹰瞳 科技(Airdoc)联合发起，人民健康支持的2025版基于视网膜人工智能评估的《六百万体检人群健康蓝皮 书》(以下简称《蓝皮书》)在北京正式发布。 长张大磊先后发言，就视网膜人工智能技术的应用发展、创新突破与普惠实践等进行了深入分享。 《六百万体检人群健康蓝皮书》发布现场 此外，现场特别设置了患者分享和专家解读环节。连续多年在爱康进行体检的谭先生因在最近一次体检 中 ...

Core Viewpoint - The 2025 "Health Green Paper for High-Net-Worth Clients in Banking and Insurance" aims to provide a comprehensive health management solution for high-net-worth individuals, emphasizing the importance of health alongside wealth, and addressing the health management gap faced by this demographic [2][3][5]. Group 1: Event Overview - The 2025 "Fortune" China 500 Summit, themed "Harnessing Trends and Expanding Territories," was held in Shanghai, gathering leaders and experts to discuss future business landscapes [2]. - Aikang Group partnered with the summit to focus on health issues for high-net-worth individuals and released the "Health Green Paper" to guide them in health management [2][3]. Group 2: Health Risks and Findings - Among 330,713 high-net-worth clients who underwent health checks, at least 605 were diagnosed with cancer, resulting in a cancer detection rate of at least 1.83‰ [8][12]. - The most common cancer diagnosed was thyroid cancer, with 214 cases, followed by lung cancer, breast cancer, and others [9][11]. - The report highlights that individuals over 40 are at a significantly higher risk for cancer, with 87.44% of diagnosed cases occurring in this age group [12][14]. Group 3: Health Management Insights - High-net-worth individuals face a "health management vacuum," often neglecting their health despite managing substantial wealth [3][22]. - The report identifies six major health traps for this demographic, including high rates of thyroid nodules (61.87%) and increased body mass index (BMI) (52.87%) [22][34]. - The prevalence of high uric acid levels and osteoporosis is alarming, with over 44% of young males (20-29 years) showing elevated uric acid levels [28][30]. Group 4: Preventive Measures and Recommendations - The report emphasizes the importance of regular health screenings, particularly for breast and cervical cancers, recommending early detection strategies for women [15][19]. - Aikang Group has established specialized centers for breast cancer screening and treatment, promoting proactive health management [19][56]. - The introduction of AI-driven personalized health checkups aims to enhance the efficiency and effectiveness of health management for high-net-worth individuals [53][55].